Global Human Vaccine Adjuvants Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 93

Published Date: 25 May 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Human Vaccine Adjuvants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Vaccine Adjuvants market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Commercial accounting for % of the Human Vaccine Adjuvants global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Aluminium Salt Adjuvant segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Human Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, and Sanofi, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Human Vaccine Adjuvants market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Aluminium Salt Adjuvant
    Oil Emulsion Adjuvant
    Others

Market segment by Application can be divided into
    Commercial
    Research

The key market players for global Human Vaccine Adjuvants market are listed below:
    GSK
    CSL Limited
    Croda
    SEPPIC
    Sanofi
    Zhifei Biological
    Escon
    Huanuotai Biological
    Rico Bio

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Vaccine Adjuvants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Vaccine Adjuvants, with price, sales, revenue and global market share of Human Vaccine Adjuvants from 2019 to 2022.
Chapter 3, the Human Vaccine Adjuvants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Vaccine Adjuvants.
Chapter 13, 14, and 15, to describe Human Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Human Vaccine Adjuvants Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Human Vaccine Adjuvants Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Aluminium Salt Adjuvant
        1.2.3 Oil Emulsion Adjuvant
        1.2.4 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Human Vaccine Adjuvants Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Commercial
        1.3.3 Research
    1.4 Global Human Vaccine Adjuvants Market Size & Forecast
        1.4.1 Global Human Vaccine Adjuvants Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Human Vaccine Adjuvants Sales in Volume (2017-2028)
        1.4.3 Global Human Vaccine Adjuvants Price (2017-2028)
    1.5 Global Human Vaccine Adjuvants Production Capacity Analysis
        1.5.1 Global Human Vaccine Adjuvants Total Production Capacity (2017-2028)
        1.5.2 Global Human Vaccine Adjuvants Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Human Vaccine Adjuvants Market Drivers
        1.6.2 Human Vaccine Adjuvants Market Restraints
        1.6.3 Human Vaccine Adjuvants Trends Analysis

2 Manufacturers Profiles
    2.1 GSK
        2.1.1 GSK Details
        2.1.2 GSK Major Business
        2.1.3 GSK Human Vaccine Adjuvants Product and Services
        2.1.4 GSK Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 CSL Limited
        2.2.1 CSL Limited Details
        2.2.2 CSL Limited Major Business
        2.2.3 CSL Limited Human Vaccine Adjuvants Product and Services
        2.2.4 CSL Limited Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Croda
        2.3.1 Croda Details
        2.3.2 Croda Major Business
        2.3.3 Croda Human Vaccine Adjuvants Product and Services
        2.3.4 Croda Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 SEPPIC
        2.4.1 SEPPIC Details
        2.4.2 SEPPIC Major Business
        2.4.3 SEPPIC Human Vaccine Adjuvants Product and Services
        2.4.4 SEPPIC Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Sanofi
        2.5.1 Sanofi Details
        2.5.2 Sanofi Major Business
        2.5.3 Sanofi Human Vaccine Adjuvants Product and Services
        2.5.4 Sanofi Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Zhifei Biological
        2.6.1 Zhifei Biological Details
        2.6.2 Zhifei Biological Major Business
        2.6.3 Zhifei Biological Human Vaccine Adjuvants Product and Services
        2.6.4 Zhifei Biological Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Escon
        2.7.1 Escon Details
        2.7.2 Escon Major Business
        2.7.3 Escon Human Vaccine Adjuvants Product and Services
        2.7.4 Escon Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Huanuotai Biological
        2.8.1 Huanuotai Biological Details
        2.8.2 Huanuotai Biological Major Business
        2.8.3 Huanuotai Biological Human Vaccine Adjuvants Product and Services
        2.8.4 Huanuotai Biological Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Rico Bio
        2.9.1 Rico Bio Details
        2.9.2 Rico Bio Major Business
        2.9.3 Rico Bio Human Vaccine Adjuvants Product and Services
        2.9.4 Rico Bio Human Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Human Vaccine Adjuvants Breakdown Data by Manufacturer
    3.1 Global Human Vaccine Adjuvants Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Human Vaccine Adjuvants Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Human Vaccine Adjuvants
    3.4 Market Concentration Rate
        3.4.1 Top 3 Human Vaccine Adjuvants Manufacturer Market Share in 2021
        3.4.2 Top 6 Human Vaccine Adjuvants Manufacturer Market Share in 2021
    3.5 Global Human Vaccine Adjuvants Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Human Vaccine Adjuvants Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Human Vaccine Adjuvants Market Size by Region
        4.1.1 Global Human Vaccine Adjuvants Sales in Volume by Region (2017-2028)
        4.1.2 Global Human Vaccine Adjuvants Revenue by Region (2017-2028)
    4.2 North America Human Vaccine Adjuvants Revenue (2017-2028)
    4.3 Europe Human Vaccine Adjuvants Revenue (2017-2028)
    4.4 Asia-Pacific Human Vaccine Adjuvants Revenue (2017-2028)
    4.5 South America Human Vaccine Adjuvants Revenue (2017-2028)
    4.6 Middle East and Africa Human Vaccine Adjuvants Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Human Vaccine Adjuvants Sales in Volume by Type (2017-2028)
    5.2 Global Human Vaccine Adjuvants Revenue by Type (2017-2028)
    5.3 Global Human Vaccine Adjuvants Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Human Vaccine Adjuvants Sales in Volume by Application (2017-2028)
    6.2 Global Human Vaccine Adjuvants Revenue by Application (2017-2028)
    6.3 Global Human Vaccine Adjuvants Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Human Vaccine Adjuvants Sales by Type (2017-2028)
    7.2 North America Human Vaccine Adjuvants Sales by Application (2017-2028)
    7.3 North America Human Vaccine Adjuvants Market Size by Country
        7.3.1 North America Human Vaccine Adjuvants Sales in Volume by Country (2017-2028)
        7.3.2 North America Human Vaccine Adjuvants Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Human Vaccine Adjuvants Sales by Type (2017-2028)
    8.2 Europe Human Vaccine Adjuvants Sales by Application (2017-2028)
    8.3 Europe Human Vaccine Adjuvants Market Size by Country
        8.3.1 Europe Human Vaccine Adjuvants Sales in Volume by Country (2017-2028)
        8.3.2 Europe Human Vaccine Adjuvants Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Human Vaccine Adjuvants Sales by Type (2017-2028)
    9.2 Asia-Pacific Human Vaccine Adjuvants Sales by Application (2017-2028)
    9.3 Asia-Pacific Human Vaccine Adjuvants Market Size by Region
        9.3.1 Asia-Pacific Human Vaccine Adjuvants Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Human Vaccine Adjuvants Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Human Vaccine Adjuvants Sales by Type (2017-2028)
    10.2 South America Human Vaccine Adjuvants Sales by Application (2017-2028)
    10.3 South America Human Vaccine Adjuvants Market Size by Country
        10.3.1 South America Human Vaccine Adjuvants Sales in Volume by Country (2017-2028)
        10.3.2 South America Human Vaccine Adjuvants Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Human Vaccine Adjuvants Sales by Type (2017-2028)
    11.2 Middle East & Africa Human Vaccine Adjuvants Sales by Application (2017-2028)
    11.3 Middle East & Africa Human Vaccine Adjuvants Market Size by Country
        11.3.1 Middle East & Africa Human Vaccine Adjuvants Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Human Vaccine Adjuvants Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Human Vaccine Adjuvants and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Human Vaccine Adjuvants
    12.3 Human Vaccine Adjuvants Production Process
    12.4 Human Vaccine Adjuvants Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Human Vaccine Adjuvants Typical Distributors
    13.3 Human Vaccine Adjuvants Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Human Vaccine Adjuvants Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Human Vaccine Adjuvants Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. GSK Basic Information, Manufacturing Base and Competitors
    Table 4. GSK Major Business
    Table 5. GSK Human Vaccine Adjuvants Product and Services
    Table 6. GSK Human Vaccine Adjuvants Sales (Tons), Price (US$/吨), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. CSL Limited Basic Information, Manufacturing Base and Competitors
    Table 8. CSL Limited Major Business
    Table 9. CSL Limited Human Vaccine Adjuvants Product and Services
    Table 10. CSL Limited Human Vaccine Adjuvants Sales (Tons), Price (US$/吨), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. Croda Basic Information, Manufacturing Base and Competitors
    Table 12. Croda Major Business
    Table 13. Croda Human Vaccine Adjuvants Product and Services
    Table 14. Croda Human Vaccine Adjuvants Sales (Tons), Price (US$/吨), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. SEPPIC Basic Information, Manufacturing Base and Competitors
    Table 16. SEPPIC Major Business
    Table 17. SEPPIC Human Vaccine Adjuvants Product and Services
    Table 18. SEPPIC Human Vaccine Adjuvants Sales (Tons), Price (US$/吨), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 20. Sanofi Major Business
    Table 21. Sanofi Human Vaccine Adjuvants Product and Services
    Table 22. Sanofi Human Vaccine Adjuvants Sales (Tons), Price (US$/吨), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Zhifei Biological Basic Information, Manufacturing Base and Competitors
    Table 24. Zhifei Biological Major Business
    Table 25. Zhifei Biological Human Vaccine Adjuvants Product and Services
    Table 26. Zhifei Biological Human Vaccine Adjuvants Sales (Tons), Price (US$/吨), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Escon Basic Information, Manufacturing Base and Competitors
    Table 28. Escon Major Business
    Table 29. Escon Human Vaccine Adjuvants Product and Services
    Table 30. Escon Human Vaccine Adjuvants Sales (Tons), Price (US$/吨), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Huanuotai Biological Basic Information, Manufacturing Base and Competitors
    Table 32. Huanuotai Biological Major Business
    Table 33. Huanuotai Biological Human Vaccine Adjuvants Product and Services
    Table 34. Huanuotai Biological Human Vaccine Adjuvants Sales (Tons), Price (US$/吨), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Rico Bio Basic Information, Manufacturing Base and Competitors
    Table 36. Rico Bio Major Business
    Table 37. Rico Bio Human Vaccine Adjuvants Product and Services
    Table 38. Rico Bio Human Vaccine Adjuvants Sales (Tons), Price (US$/吨), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. Global Human Vaccine Adjuvants Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Tons)
    Table 40. Global Human Vaccine Adjuvants Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 41. Market Position of Manufacturers in Human Vaccine Adjuvants, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 42. Global Human Vaccine Adjuvants Production Capacity by Company, (Tons): 2020 VS 2021
    Table 43. Head Office and Human Vaccine Adjuvants Production Site of Key Manufacturer
    Table 44. Human Vaccine Adjuvants New Entrant and Capacity Expansion Plans
    Table 45. Human Vaccine Adjuvants Mergers & Acquisitions in the Past Five Years
    Table 46. Global Human Vaccine Adjuvants Sales by Region (2017-2022) & (Tons)
    Table 47. Global Human Vaccine Adjuvants Sales by Region (2023-2028) & (Tons)
    Table 48. Global Human Vaccine Adjuvants Revenue by Region (2017-2022) & (USD Million)
    Table 49. Global Human Vaccine Adjuvants Revenue by Region (2023-2028) & (USD Million)
    Table 50. Global Human Vaccine Adjuvants Sales by Type (2017-2022) & (Tons)
    Table 51. Global Human Vaccine Adjuvants Sales by Type (2023-2028) & (Tons)
    Table 52. Global Human Vaccine Adjuvants Revenue by Type (2017-2022) & (USD Million)
    Table 53. Global Human Vaccine Adjuvants Revenue by Type (2023-2028) & (USD Million)
    Table 54. Global Human Vaccine Adjuvants Price by Type (2017-2022) & (US$/吨)
    Table 55. Global Human Vaccine Adjuvants Price by Type (2023-2028) & (US$/吨)
    Table 56. Global Human Vaccine Adjuvants Sales by Application (2017-2022) & (Tons)
    Table 57. Global Human Vaccine Adjuvants Sales by Application (2023-2028) & (Tons)
    Table 58. Global Human Vaccine Adjuvants Revenue by Application (2017-2022) & (USD Million)
    Table 59. Global Human Vaccine Adjuvants Revenue by Application (2023-2028) & (USD Million)
    Table 60. Global Human Vaccine Adjuvants Price by Application (2017-2022) & (US$/吨)
    Table 61. Global Human Vaccine Adjuvants Price by Application (2023-2028) & (US$/吨)
    Table 62. North America Human Vaccine Adjuvants Sales by Country (2017-2022) & (Tons)
    Table 63. North America Human Vaccine Adjuvants Sales by Country (2023-2028) & (Tons)
    Table 64. North America Human Vaccine Adjuvants Revenue by Country (2017-2022) & (USD Million)
    Table 65. North America Human Vaccine Adjuvants Revenue by Country (2023-2028) & (USD Million)
    Table 66. North America Human Vaccine Adjuvants Sales by Type (2017-2022) & (Tons)
    Table 67. North America Human Vaccine Adjuvants Sales by Type (2023-2028) & (Tons)
    Table 68. North America Human Vaccine Adjuvants Sales by Application (2017-2022) & (Tons)
    Table 69. North America Human Vaccine Adjuvants Sales by Application (2023-2028) & (Tons)
    Table 70. Europe Human Vaccine Adjuvants Sales by Country (2017-2022) & (Tons)
    Table 71. Europe Human Vaccine Adjuvants Sales by Country (2023-2028) & (Tons)
    Table 72. Europe Human Vaccine Adjuvants Revenue by Country (2017-2022) & (USD Million)
    Table 73. Europe Human Vaccine Adjuvants Revenue by Country (2023-2028) & (USD Million)
    Table 74. Europe Human Vaccine Adjuvants Sales by Type (2017-2022) & (Tons)
    Table 75. Europe Human Vaccine Adjuvants Sales by Type (2023-2028) & (Tons)
    Table 76. Europe Human Vaccine Adjuvants Sales by Application (2017-2022) & (Tons)
    Table 77. Europe Human Vaccine Adjuvants Sales by Application (2023-2028) & (Tons)
    Table 78. Asia-Pacific Human Vaccine Adjuvants Sales by Region (2017-2022) & (Tons)
    Table 79. Asia-Pacific Human Vaccine Adjuvants Sales by Region (2023-2028) & (Tons)
    Table 80. Asia-Pacific Human Vaccine Adjuvants Revenue by Region (2017-2022) & (USD Million)
    Table 81. Asia-Pacific Human Vaccine Adjuvants Revenue by Region (2023-2028) & (USD Million)
    Table 82. Asia-Pacific Human Vaccine Adjuvants Sales by Type (2017-2022) & (Tons)
    Table 83. Asia-Pacific Human Vaccine Adjuvants Sales by Type (2023-2028) & (Tons)
    Table 84. Asia-Pacific Human Vaccine Adjuvants Sales by Application (2017-2022) & (Tons)
    Table 85. Asia-Pacific Human Vaccine Adjuvants Sales by Application (2023-2028) & (Tons)
    Table 86. South America Human Vaccine Adjuvants Sales by Country (2017-2022) & (Tons)
    Table 87. South America Human Vaccine Adjuvants Sales by Country (2023-2028) & (Tons)
    Table 88. South America Human Vaccine Adjuvants Revenue by Country (2017-2022) & (USD Million)
    Table 89. South America Human Vaccine Adjuvants Revenue by Country (2023-2028) & (USD Million)
    Table 90. South America Human Vaccine Adjuvants Sales by Type (2017-2022) & (Tons)
    Table 91. South America Human Vaccine Adjuvants Sales by Type (2023-2028) & (Tons)
    Table 92. South America Human Vaccine Adjuvants Sales by Application (2017-2022) & (Tons)
    Table 93. South America Human Vaccine Adjuvants Sales by Application (2023-2028) & (Tons)
    Table 94. Middle East & Africa Human Vaccine Adjuvants Sales by Region (2017-2022) & (Tons)
    Table 95. Middle East & Africa Human Vaccine Adjuvants Sales by Region (2023-2028) & (Tons)
    Table 96. Middle East & Africa Human Vaccine Adjuvants Revenue by Region (2017-2022) & (USD Million)
    Table 97. Middle East & Africa Human Vaccine Adjuvants Revenue by Region (2023-2028) & (USD Million)
    Table 98. Middle East & Africa Human Vaccine Adjuvants Sales by Type (2017-2022) & (Tons)
    Table 99. Middle East & Africa Human Vaccine Adjuvants Sales by Type (2023-2028) & (Tons)
    Table 100. Middle East & Africa Human Vaccine Adjuvants Sales by Application (2017-2022) & (Tons)
    Table 101. Middle East & Africa Human Vaccine Adjuvants Sales by Application (2023-2028) & (Tons)
    Table 102. Human Vaccine Adjuvants Raw Material
    Table 103. Key Manufacturers of Human Vaccine Adjuvants Raw Materials
    Table 104. Direct Channel Pros & Cons
    Table 105. Indirect Channel Pros & Cons
    Table 106. Human Vaccine Adjuvants Typical Distributors
    Table 107. Human Vaccine Adjuvants Typical Customers
List of Figures
    Figure 1. Human Vaccine Adjuvants Picture
    Figure 2. Global Human Vaccine Adjuvants Revenue Market Share by Type in 2021
    Figure 3. Aluminium Salt Adjuvant
    Figure 4. Oil Emulsion Adjuvant
    Figure 5. Others
    Figure 6. Global Human Vaccine Adjuvants Revenue Market Share by Application in 2021
    Figure 7. Commercial
    Figure 8. Research
    Figure 9. Global Human Vaccine Adjuvants Revenue, (USD Million) & (Tons): 2017 & 2021 & 2028
    Figure 10. Global Human Vaccine Adjuvants Revenue and Forecast (2017-2028) & (USD Million)
    Figure 11. Global Human Vaccine Adjuvants Sales (2017-2028) & (Tons)
    Figure 12. Global Human Vaccine Adjuvants Price (2017-2028) & (US$/吨)
    Figure 13. Global Human Vaccine Adjuvants Production Capacity (2017-2028) & (Tons)
    Figure 14. Global Human Vaccine Adjuvants Production Capacity by Geographic Region: 2022 VS 2028
    Figure 15. Human Vaccine Adjuvants Market Drivers
    Figure 16. Human Vaccine Adjuvants Market Restraints
    Figure 17. Human Vaccine Adjuvants Market Trends
    Figure 18. Global Human Vaccine Adjuvants Sales Market Share by Manufacturer in 2021
    Figure 19. Global Human Vaccine Adjuvants Revenue Market Share by Manufacturer in 2021
    Figure 20. Human Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 21. Top 3 Human Vaccine Adjuvants Manufacturer (Revenue) Market Share in 2021
    Figure 22. Top 6 Human Vaccine Adjuvants Manufacturer (Revenue) Market Share in 2021
    Figure 23. Global Human Vaccine Adjuvants Sales Market Share by Region (2017-2028)
    Figure 24. Global Human Vaccine Adjuvants Revenue Market Share by Region (2017-2028)
    Figure 25. North America Human Vaccine Adjuvants Revenue (2017-2028) & (USD Million)
    Figure 26. Europe Human Vaccine Adjuvants Revenue (2017-2028) & (USD Million)
    Figure 27. Asia-Pacific Human Vaccine Adjuvants Revenue (2017-2028) & (USD Million)
    Figure 28. South America Human Vaccine Adjuvants Revenue (2017-2028) & (USD Million)
    Figure 29. Middle East & Africa Human Vaccine Adjuvants Revenue (2017-2028) & (USD Million)
    Figure 30. Global Human Vaccine Adjuvants Sales Market Share by Type (2017-2028)
    Figure 31. Global Human Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
    Figure 32. Global Human Vaccine Adjuvants Price by Type (2017-2028) & (US$/吨)
    Figure 33. Global Human Vaccine Adjuvants Sales Market Share by Application (2017-2028)
    Figure 34. Global Human Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
    Figure 35. Global Human Vaccine Adjuvants Price by Application (2017-2028) & (US$/吨)
    Figure 36. North America Human Vaccine Adjuvants Sales Market Share by Type (2017-2028)
    Figure 37. North America Human Vaccine Adjuvants Sales Market Share by Application (2017-2028)
    Figure 38. North America Human Vaccine Adjuvants Sales Market Share by Country (2017-2028)
    Figure 39. North America Human Vaccine Adjuvants Revenue Market Share by Country (2017-2028)
    Figure 40. United States Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 41. Canada Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Mexico Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Europe Human Vaccine Adjuvants Sales Market Share by Type (2017-2028)
    Figure 44. Europe Human Vaccine Adjuvants Sales Market Share by Application (2017-2028)
    Figure 45. Europe Human Vaccine Adjuvants Sales Market Share by Country (2017-2028)
    Figure 46. Europe Human Vaccine Adjuvants Revenue Market Share by Country (2017-2028)
    Figure 47. Germany Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. France Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. United Kingdom Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Russia Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Italy Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Asia-Pacific Human Vaccine Adjuvants Sales Market Share by Region (2017-2028)
    Figure 53. Asia-Pacific Human Vaccine Adjuvants Sales Market Share by Application (2017-2028)
    Figure 54. Asia-Pacific Human Vaccine Adjuvants Sales Market Share by Region (2017-2028)
    Figure 55. Asia-Pacific Human Vaccine Adjuvants Revenue Market Share by Region (2017-2028)
    Figure 56. China Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Japan Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Korea Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. India Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Southeast Asia Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Australia Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South America Human Vaccine Adjuvants Sales Market Share by Type (2017-2028)
    Figure 63. South America Human Vaccine Adjuvants Sales Market Share by Application (2017-2028)
    Figure 64. South America Human Vaccine Adjuvants Sales Market Share by Country (2017-2028)
    Figure 65. South America Human Vaccine Adjuvants Revenue Market Share by Country (2017-2028)
    Figure 66. Brazil Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Argentina Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Middle East & Africa Human Vaccine Adjuvants Sales Market Share by Type (2017-2028)
    Figure 69. Middle East & Africa Human Vaccine Adjuvants Sales Market Share by Application (2017-2028)
    Figure 70. Middle East & Africa Human Vaccine Adjuvants Sales Market Share by Region (2017-2028)
    Figure 71. Middle East & Africa Human Vaccine Adjuvants Revenue Market Share by Region (2017-2028)
    Figure 72. Turkey Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Egypt Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Saudi Arabia Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. South Africa Human Vaccine Adjuvants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Manufacturing Cost Structure Analysis of Human Vaccine Adjuvants in 2021
    Figure 77. Manufacturing Process Analysis of Human Vaccine Adjuvants
    Figure 78. Human Vaccine Adjuvants Industrial Chain
    Figure 79. Sales Channel: Direct Channel vs Indirect Channel
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GSK
CSL Limited
Croda
SEPPIC
Sanofi
Zhifei Biological
Escon
Huanuotai Biological
Rico Bio

Related Reports

Global Human Vaccine Adjuvants Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Human Vaccine Adjuvants Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Vaccine Adjuvants market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Human Vaccine Adjuvants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Human Vaccine Adjuvants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Vaccine Adjuvants market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Human Vaccine Adjuvants Supply, Demand and Key Producers, 2024-2030

Global Human Vaccine Adjuvants Supply, Demand and Key Producers, 2024-2030

date 01 Apr 2024

date Pharma & Healthcare

The global Human Vaccine Adjuvants market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

human vaccine adjuvants

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>